| # | Country | Total Patents | |
|---|---|---|---|
| #1 | United States | 6 | |
| #2 | Australia | 5 | |
| #3 | EPO (European Patent Office) | 4 | |
| #4 | WIPO (World Intellectual Property Organization) | 3 | |
| #5 | New Zealand | 2 |
| # | Industry | |
|---|---|---|
| #1 | Pharmaceuticals | |
| #2 | Biotechnology | |
| #3 | Machines |
| # | Technology | |
|---|---|---|
| #1 | Medical preparations | |
| #2 | Therapeutic chemical compounds | |
| #3 | Microorganisms | |
| #4 | Unspecified technologies | |
| #5 | Peptides |
| # | Name | Total Patents |
|---|---|---|
| #1 | Schroder Ulf | 11 |
| #2 | Svenson Stefan | 8 |
| #3 | Schroeder Ulf | 7 |
| #4 | Hinkula Jorma | 5 |
| #5 | De Carvalho Nicacio Cristina A | 1 |
| #6 | Eurocine Ab | 1 |
| #7 | Lundkvist Aake | 1 |
| Publication | Filing date | Title |
|---|---|---|
| AU2003292136A1 | Vaccines against viruses with cationic substances as adjuvants | |
| WO02053183A1 | Hantavirus vaccin with adjuvant | |
| AU2547300A | Vaccine formulation | |
| EP1154792A2 | Tuberculosis vaccine formulation comprising monoglycerides or fatty acids as adjuvant | |
| US7128909B2 | Immunstimulating lipid formulation |